Acute and repeated administration of the selective 5-HT2A receptor antagonist m100907 significantly alters the activity of midbrain dopamine neurons: An in vivo electrophysiological study

Synapse

Volumn 40, Issue 2, 2001, Pages 102-112

  Minabe, Yoshio ^a,b   Hashimoto, Kenji ^c   Watanabe, Kei Ichiro ^d   Ashby, Charles R ^e  

^a Ishikawa Prefectural Takamatsu Hospital   (Japan)

^b National Institute for Neuroscience   (Japan)

^c Yoshitomi Pharmaceutical Industries Ltd   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e ST JOHN'S UNIVERSITY   (United States)

Author keywords

Electrophysiology; M100907; Substantia nigra pars compacta; Ventral tegmental area

Indexed keywords

ALPHA (2,3 DIMETHOXYPHENYL) 1 [2 (4 FLUOROPHENYL)ETHYL] 4 PIPERIDINEMETHANOL; SEROTONIN 2A ANTAGONIST;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL COUNT; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; ELECTROPHYSIOLOGY; MALE; MESENCEPHALON; NONHUMAN; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA; VENTRAL TEGMENTUM;

ACTION POTENTIALS; ANIMALS; DOPAMINE; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FLUOROBENZENES; HALOPERIDOL; INJECTIONS, INTRAVENOUS; MALE; NEURONS; PIPERIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, SEROTONIN; SEROTONIN ANTAGONISTS; SUBSTANTIA NIGRA; VENTRAL TEGMENTAL AREA;

EID: 0035077696     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/syn.1031     Document Type: Article

References (50)

1. Pharmacological actions of the atypical antipsychotic drug clozapine: A review
2. 3 receptor antagonist, on spontaneously active midbrain dopaminergic cells in the rat
3. 1 receptor antagonist CP 96,345 on midbrain DA neurons: An in vivo electrophysiological study
4. Acute and chronic haloperidol treatment: Comparison of effects of nigral dopaminergic cell activity
5. Dopaminergic neurons: Effect of antipsychotic drugs and amphetamines on single cell activity
6. Dopamine-containing neurons in the mammalian central nervous system: Electrophysiology and pharmacology
7. Typical and atypical neuroleptics: Differential effects of chronic administration on the activity of A9 and A10 dopamine neurons
8. 2A receptor in the central nervous system of the rat
9. Ultrastructural localization of the serotonin 2A receptor in dopaminergic neurons in the ventral tegmental area
10. Chronic neuroleptic effects on dopamine neuron activity: A model for predicting therapeutic efficacy and side effects
11. Burst firing induced in midbrain dopamine neurons by stimulation of the medial prefrontal cortex and anterior cingulate cortices
12. Nonlinear relationship between impulse flow and dopamine released by midbrain dopaminergic neurons as studied by in vivo electrochemistry
13. The depolarization block hypothesis of neuroleptic action: Implications for the etiology and treatment of schizophrenia
14. The control of firing pattern in nigral dopamine neurons: Burst firing
15. Induction of depolarization block in midbrain dopamine neurons by repeated administration of haloperidol: Analysis using in vivo intracellular recording
16. Acute haloperidol administration induces depolarization block of nigral dopamine neurons in rats after partial dopamine lesions
17. Electrophysiological, biochemical, and behavioral studies of acute haloperidol-induced depolarization block of nigral dopamine neurons
18. 2A antagonists with a favorable CNS safety profile
19. 2 receptor by in situ hybridization. Correlation with the distribution of receptor sites
20. Regional and cellular distribution of serotonin 5-hydroxytryptamine 2a receptor mRNA in the nucleus accumbens, olfactory tubercle, and caudate-putamen of the rat
21. 3 antagonists granisetron and LY 277359 potentiate the suppressant action of (+)-apomorphine on the basal firing rate of ventral tegmental dopamine cells
22. 3 receptor antagonist, on spontaneously active midbrain dopamine cells
23. B receptor antagonist L-365,260, reverses the effects of chronic haloperidol and clozapine on midbrain dopamine neurons in the rat
24. The effect of acute and chronic granisetron alone or in combination with haloperidol on midbrain dopamine neurons in the rat
25. 2 receptor antagonist SR48968 on midbrain dopamine neurons in the rat: An in vivo extracellular single cell study
26. Differential effects of chronic haloperidol administration on midbrain dopamine neurons in Sprague-Dawley, Fischer 344 and Lewis rats: An in vivo electrophysiological study
27. Burst firing in midbrain dopaminergic neurons
28. A pharmacological analysis of the burst events induced in midbrain dopaminergic neurons by electrical stimulation of the medial prefrontal cortex in the rat
29. 3 mediated control of dopaminergic function
30. Quantitative autoradiographic mapping of serotonin receptors in the rat brain. II. Serotonin-2 receptors
31. 2B receptors
32. 3 receptor antagonist zatosetron decreases the number of spontaneously active A10 dopamine neurons
33. Cholecystokinin (CCK) and schizophrenia: The selective CCKB antagonist LY262691 decreases midbrain dopamine unit activity
34. N-methyl-D-aspartate (NMDA) receptors in the ventral tegmental area: Subcellular distribution and colocalization with 5-hydroxytryptamine(2A) receptors
35. 4 receptors
36. 2A receptor antagonist, MDL 100,907, increases dopamine efflux in the prefrontal cortex in the rat
37. Selective 5-hydroxy-tryptamine2 receptor antagonists protect against the neurotoxicity of methylenedioxymeth-amphetamine in rats
38. 2 receptor antagonist, MDL 28,133A, disrupts the serotonergic-dopaminergic interaction mediating the neurochemical effects of 3,4-methylenedioxymethamphetamine
39. 2 receptors exert a state-dependent regulation of dopaminergic function: Studies with MDL 100,907 and the amphetamine analogue, 3,4-methylenedioxymethamphetamine
40. 2A receptors in antipsychotic activity
41. Investigation of the CNS penetration of a potent 5-HT2A receptor antagonist (MDL 100.907) and an active metabolite (MDL 105,725) using in vivo microdialysis sampling in the rats
42. Differential effects after repeated administration with haloperidol, clozapine, thioridazine and tefludazine on SNC and VTA dopaminergic neurons
43. Comparison of short-term administration of sertindole, clozapine and haloperidol on the inactivation of dopamine neurons in the rat
44. 3 receptor antagonist, on A9 and A10 dopamine cells
45. 2 antagonists reverse amphetamine-induced slowing of dopaminergic neurons by interfering with stimulated dopamine synthesis
46. 2 receptor antagonist MDL 100907 as a putative atypical antipsychotic: Behavioral, electrophysiological and neurochemical studies
47. Dopaminergic neurons in the rat ventral tegmental area. I. Identification and characterization
48. 6 with neuropeptides in rat striatum
49. Differential effects of classical and atypical antipsychotic drugs on A9 and A10 dopamine neurons